Roderick.r
Non-executive Director)
sigmoid pharma
Ireland
Biography
Mr. Ryan is a former Managing Partner of Arthur Andersen in Ireland and has an extensive knowledge of financial reporting, corporate taxation, governance and regulatory developments
Research Interest
SmPill® is the main focus of Sigmoid’s current development work and underpins all product development programmes. CyCol®, Sigmoid’s lead clinical development program, which is advancing into Phase 3 trials for moderate to severe ulcerative colitis, was uniquely enabled using SmPill® drug delivery technology.
